BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 9933348)

  • 41. Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.
    Kuwert T; Probst-Cousin S; Woesler B; Morgenroth C; Lerch H; Matheja P; Palkovic S; Schäfers M; Wassmann H; Gullotta F; Schober O
    J Nucl Med; 1997 Oct; 38(10):1551-5. PubMed ID: 9379191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of pathology and survival by FDG PET in gliomas.
    Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
    J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
    J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
    Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
    Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
    Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
    Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of [18F]FDG-PET and L-3[123I]-iodo-alpha-methyl tyrosine (I-123 IMT)-SPECT in primary lung cancer.
    Willkomm P; Bangard M; Guhlke S; Sartor J; Bender H; Gallkowski U; Reichmann K; Biersack HJ
    Ann Nucl Med; 2002 Nov; 16(7):503-6. PubMed ID: 12508845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.
    Derlon JM; Chapon F; Noël MH; Khouri S; Benali K; Petit-Taboué MC; Houtteville JP; Chajari MH; Bouvard G
    Eur J Nucl Med; 2000 Jul; 27(7):778-87. PubMed ID: 10952489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation.
    Kwon JW; Kim IO; Cheon JE; Kim WS; Moon SG; Kim TJ; Chi JG; Wang KC; Chung JK; Yeon KM
    Pediatr Radiol; 2006 Sep; 36(9):959-64. PubMed ID: 16847598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride.
    Tamura M; Shibasaki T; Zama A; Kurihara H; Horikoshi S; Ono N; Oriuchi N; Hirano T
    Neuroradiology; 1998 Apr; 40(4):210-5. PubMed ID: 9592789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FDG-PET as a prognostic factor in high-grade astrocytoma.
    De Witte O; Lefranc F; Levivier M; Salmon I; Brotchi J; Goldman S
    J Neurooncol; 2000 Sep; 49(2):157-63. PubMed ID: 11206011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
    Higashi K; Ueda Y; Matsunari I; Kodama Y; Ikeda R; Miura K; Taki S; Higuchi T; Tonami H; Yamamoto I
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):13-21. PubMed ID: 14574513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early effects of irradiation on [(123)I]-IMT and [(18)F]-FDG uptake in rat C6 glioma cells.
    Riemann B; Könemann S; Pöpping D; Kopka K; Weckesser M; Willich N; Schober O
    Strahlenther Onkol; 2004 Jul; 180(7):434-41. PubMed ID: 15241531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
    Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
    J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
    Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
    J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
    Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
    Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
    Bénard F; Romsa J; Hustinx R
    Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.